Status:
COMPLETED
A Phase I Study in Healthy Volunteers to Assess Dosimetry and Safety Following Injection of BMS747158 at Stress
Lead Sponsor:
Lantheus Medical Imaging
Conditions:
Healthy Volunteers
Eligibility:
All Genders
18-40 years
Phase:
PHASE1
Brief Summary
The purpose of this clinical research study is to learn the biodistribution of injection of BMS747158 at stress and assess the safety of two doses of BMS747158
Eligibility Criteria
Inclusion
- age 18-40
- BMI 18-30 kg/m2
- No active or chronic illnesses
- If female: not pregnant, use of birth control or not of child-bearing potential
Exclusion
- Significant active or chronic illness
- Any neurological disorder
- GI disease within 3 months
- Recent infection
- Major surgery within 4 weeks
- Donation of blood within 4 weeks
- Blood transfusion within 4 weeks
- Recent history drug/alcohol abuse
- Head trauma
- Significant screening ECG, EEG, lab tests, physical exam and vital signs abnormalities
- Prescription or OTC drugs within 2 weeks
- Exposure to any other investigational
Key Trial Info
Start Date :
June 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2008
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT00707538
Start Date
June 1 2008
End Date
October 1 2008
Last Update
November 10 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
UCLA Medical Center
Los Angeles, California, United States, 90095
2
John Hopkins University
Baltimore, Maryland, United States, 21287